Abstract

The early monitoring of TNF-α has important clinical significance for newborn disease screening. Therefore, a reusable electrochemical aptasensor based on CeO2@Au nanorods-PAMAM-ferrocene (Ce@AuNRs-PAMAM-Fc) and enzyme-free DNA walker technology was developed for the ultrasensitive detection of TNF-α. To amplify the signal, Ce@AuNRs was prepared by in situ synthesis of gold nanoparticles on the surface of CeO2NRs and connected with PAMAM-COOH and Fc-COOH to form Ce@AuNRs-PAMAM-Fc. As signal tags, Ce@AuNRs-PAMAM-Fc could catalyze the redox reaction of H2O2 with the changes in current signals. In addition, the enzyme-free DNA walker technology was used to continuously cleave the signal probe to achieve the dual-amplification of the signal. The developed aptasensor could detect TNF-α in the range of 2 to 2 × 106 pg/mL, with a detection limit of 0.6 pg/mL. It is worth mentioning that the combination of DNA walker and strand displacement technology made the aptasensor reused up to 7 times, greatly reducing the detection cost. In summary, the highly sensitive and reusable aptasensor is a promising strategy for the early screening of neonatal diseases.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.